Tetrahydrobenzothiophene carboxamides: Beyond the kinase domain and into the fatty acid realm
- 1 September 2017
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (18) , 4462-4466
Abstract
No abstract availableKeywords
Funding Information
- Swedish Research Council
- Knut and Alice Wallenberg Foundation
- Göran Gustafsson Foundation
- Swedish Pain Relief Foundation
- Torsten Söderbergs Stiftelse
- Swedish Children’s Cancer Foundation
- Swedish Cancer Society
This publication has 28 references indexed in Scilit:
- Discovery of Piperazin-1-ylpyridazine-Based Potent and Selective Stearoyl-CoA Desaturase-1 Inhibitors for the Treatment of Obesity and Metabolic SyndromeJournal of Medicinal Chemistry, 2013
- Hepatocyte-specific Deletion of Janus Kinase 2 (JAK2) Protects against Diet-induced Steatohepatitis and Glucose IntoleranceJournal of Biological Chemistry, 2012
- Development of a Liver-Targeted Stearoyl-CoA Desaturase (SCD) Inhibitor (MK-8245) to Establish a Therapeutic Window for the Treatment of Diabetes and DyslipidemiaJournal of Medicinal Chemistry, 2011
- Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyondNature Reviews Drug Discovery, 2011
- Synthesis and biological activity of a potent and orally bioavailable SCD inhibitor (MF-438)Bioorganic & Medicinal Chemistry Letters, 2010
- Thiazole analog as stearoyl-CoA desaturase 1 inhibitorBioorganic & Medicinal Chemistry Letters, 2009
- Discovery of Potent, Selective, Orally Bioavailable Stearoyl-CoA Desaturase 1 InhibitorsJournal of Medicinal Chemistry, 2007
- Regulation of Dendritic Cell Differentiation and Antitumor Immune Response in Cancer by Pharmacologic-Selective Inhibition of the Janus-Activated Kinase 2/Signal Transducers and Activators of Transcription 3 PathwayCancer Research, 2005
- Stearoyl‐CoA desaturase as a new drug target for obesity treatmentObesity Reviews, 2005
- Recent insights into stearoyl-CoA desaturase-1Current Opinion in Lipidology, 2003